Non-consolidated Financial Results for the Six Months Ended June 30, 2026 [Under Japanese GAAP]8/5 15:30TDnetPDF(284KB)
ドラッグデリバリーシステム「Perfusio」の事業化に向けた医薬品医療機器総合機構(PMDA)との医療機器・体外診断用医薬品 対面助言準備面談実施のお知らせ5/18 12:30TDnetPDF(323KB)
SpiroChem and Veritas In Silico entered into Joint Research Agreement to Initiate the Discovery of Next Generation mRNA Binding Chemical Matter5/11 15:30TDnetPDF(354KB)
Non-consolidated Financial Results for the Three Months Ended March 31,2026 [Under Japanese GAAP]5/11 15:30TDnetPDF(246KB)
Termination of Collaborative Drug Discovery Research with Takeda on mRNA-Targeted Small-Molecule Drugs4/13 15:30TDnetPDF(162KB)
Appointing Candidates for Directors, Auditor, and Alternate Audit & Supervisory Board Member2/19 18:00TDnetPDF(310KB)